Bioceres Crop Solutions Corp. (BIOX)
NASDAQ: BIOXIndustrialsAgricultural ChemicalsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BIOX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $11.04M
- Forward P/E
- 0.27
- EPS (TTM)
- -$1.20
- Dividend yield
- None
- 52-week range
- 0.1619 – 1.73
- Day range
- 0.1619 – 0.18
- Volume / Avg
- 130.22K / 304.62K
- Beta
- —
- Shares outstanding
- 63.82M
52-week range
BIOX stock today
Bioceres Crop Solutions (BIOX) closed at $0.173 on Nov 20, down 5.41% (-$0.0099), versus the S&P 500's 3.70% decline. Trading was light, with 130.22K shares changing hands, about 43% of the average daily volume. At this level, BIOX sits near the bottom of its 52-week range of $0.1619 to $1.73: 90.0% below the high, set on Nov 28, 2025 and 6.9% above the low.
BIOX is down 86.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 88.4%. Bioceres Crop Solutions has posted a net loss over the last twelve months (EPS of -$1.20), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Bioceres Crop Solutions
Company profileBioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops.
- Sector
- Industrials
- Industry
- Agricultural Chemicals
- CEO
- Dr. Federico Trucco Ph.D.
- Headquarters
- Rosario
Financial highlights
Full financialsIn fiscal 2025, Bioceres Crop Solutions generated $335.1 million in revenue, down 27.9% from fiscal 2024, the first decline in the 9 years shown. Bioceres Crop Solutions reported a net loss of $55.4 million, compared with net income of $4.3 million a year earlier. Gross margin was 39.3% (down from 40.1%) and operating margin -0.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $335.11M | $464.78M | $420.06M | $334.84M | $209.53M |
| Growth | -27.90% | +10.65% | +25.45% | +59.81% | +21.05% |
| Net income | $-55.42M | $4.28M | $18.78M | $-7.20M | $-6.87M |
| EPS (diluted) | $-0.8764 | $0.0673 | $0.2972 | $-0.1702 | $-0.1752 |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 11, 2026
- EPS actual vs est.
- $-0.12 vs —
BIOX news
All BIOX newsBioceres Crop Solutions peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| FRTTFort Technology Inc. | 0.47 | -9.79% | $7.14M | vs BIOX |
| EVGNEvogene Ltd | 0.3162 | +1.02% | $5.71M | vs BIOX |
| SNESSenesTech Inc. | 0.69 | +6.15% | $4.71M | vs BIOX |
| AVDAmerican Vanguard Corporation | 0.68 | -1.48% | $20.10M | vs BIOX |
| NXTSNexentis Technologies Inc. | 1.58 | -7.06% | $1.05M | vs BIOX |
| ICLICL Group Ltd. | 4.08 | -1.45% | — | vs BIOX |
| UANCVR Partners LP | 95.09 | -0.88% | — | vs BIOX |
| CBUSCibus Inc. Class A | 1.21 | -1.63% | $92.73M | vs BIOX |
Indexes, lists and sector
Bioceres Crop Solutions stock FAQ
What is Bioceres Crop Solutions's stock price today?
BIOX last traded at $0.173 as of Nov 20, 4:00 PM EST, down 5.41% on the day. Prices are delayed at least 15 minutes.
Who is Bioceres Crop Solutions's CEO?
Dr. Federico Trucco Ph.D. is the chief executive officer of Bioceres Crop Solutions Corp..
What is the BIOX 52-week high?
The 52-week high for BIOX is $1.73 and the 52-week low is $0.1619. The stock is currently 90.0% below its high.